This document reviews fibromyalgia and chronic fatigue syndrome, discussing their definitions, epidemiology, pathophysiology, symptoms, theories of causation, and treatment options. It examines various theories that fibromyalgia may be caused by abnormalities in brain chemistry, hormones, muscle and cell function. Both pharmacological and non-pharmacological therapies are considered, including medications, diet, exercise, sleep, and supplements. Specific evaluation and treatment approaches focused on the thyroid, adrenals, sleep, fatigue, stress reduction, and pain management are outlined.
I was asked to present something on Fibromyalgia during a Pain Summit. I ended up describing what we know so far about clinical features, evolution of diagnostic criteria and synthesized some recent guidelines.
I was asked to present something on Fibromyalgia during a Pain Summit. I ended up describing what we know so far about clinical features, evolution of diagnostic criteria and synthesized some recent guidelines.
Have you ever had one of those extreme headaches that ruthlessly affect your quality of work? If you are suffering from chronic widespread pain and sharp painful response to pressure, known as allodynia in medical terms, then you might be experiencing Fibromyalgia.
Fibromyalgia is a disease, which is difficult to diagnose. These slides include ACR criteria 1990 and 2010 with Wide spread pain index(WPI) and Symptom severity score(SSS)
Dr Richard Schloeffel - Chronic Fatigue Syndrome Diagnosis and TreatmentPeer Support Network
Emerge Australia seminar 13 September 2014.
Dr Richard Schloeffel graduated in 1978 from NSW Uni with post -graduate training in isolated rural general practice. He worked in country practices for thirteen years and spent five years working in the developing world, including Papua New Guinea, China, India, Bali and Eastern Europe. For the last twenty years He has been the principal at ‘Pymble Grove Health Centre’ where he has been treating and specializing in complex and chronic disorders with an integrative team of practitioners.
This broad experience has been invaluable in developing the diagnosis and treatment of chronic disorders and the ability to look beyond the existing paradigms to a deeper and more profound understanding of complex disease, particularly Chronic Fatigue Syndrome, Borreliosis and its co-infections and Auto Immune Disease.
Dr Schloeffel has treated over three and a half thousand patients with Chronic Fatigue Syndrome and related disorders, refining diagnosis and appropriate investigations and management protocols. He has lectured widely on CFS and is currently undertaking research at Sydney University into Australian Lyme Disease.
Fibromyalgia syndrome is a common and chronic disorder characterized
by widespread pain, diffuse tenderness, and a number of other symptoms.
The word “fibromyalgia” comes from the Latin term for fibrous tissue (fibro) and the Greek ones for muscle (myo) and pain (algia).
Although fibromyalgia is often considered an arthritis-related
condition, it is not truly a form of arthritis (a disease of the joints)
because it does not cause inflammation or damage to the joints,
muscles, or other tissues. Like arthritis, however, fibromyalgia can
cause significant pain and fatigue, and it can interfere with a person’s
ability to carry on daily activities. Also like arthritis, fibromyalgia
is considered a rheumatic condition, a medical condition that impairs
the joints and/or soft tissues and causes chronic pain.
In addition to pain and fatigue, people who have fibromyalgia may experience a variety of other symptoms including:
-- cognitive and memory problems (sometimes referred to as “fibro fog”)
-- sleep disturbances
-- morning stiffness
-- headaches
-- irritable bowel syndrome
-- painful menstrual periods
-- numbness or tingling of the extremities
-- restless legs syndrome
-- temperature sensitivity
-- sensitivity to loud noises or bright lights.
Fibromyalgia is a syndrome rather than a disease. A syndrome is a
collection of signs, symptoms, and medical problems that tend to occur
together but are not related to a specific, identifiable cause. A
disease, on the other hand, has a specific cause or causes and
recognizable signs and symptoms.
A person may have two or more coexisting chronic pain conditions.
Such conditions can include chronic fatigue syndrome, endometriosis,
fibromyalgia, inflammatory bowel disease, interstitial cystitis,
temporomandibular joint dysfunction, and vulvodynia. It is not known
whether these disorders share a common cause.
Have you ever had one of those extreme headaches that ruthlessly affect your quality of work? If you are suffering from chronic widespread pain and sharp painful response to pressure, known as allodynia in medical terms, then you might be experiencing Fibromyalgia.
Fibromyalgia is a disease, which is difficult to diagnose. These slides include ACR criteria 1990 and 2010 with Wide spread pain index(WPI) and Symptom severity score(SSS)
Dr Richard Schloeffel - Chronic Fatigue Syndrome Diagnosis and TreatmentPeer Support Network
Emerge Australia seminar 13 September 2014.
Dr Richard Schloeffel graduated in 1978 from NSW Uni with post -graduate training in isolated rural general practice. He worked in country practices for thirteen years and spent five years working in the developing world, including Papua New Guinea, China, India, Bali and Eastern Europe. For the last twenty years He has been the principal at ‘Pymble Grove Health Centre’ where he has been treating and specializing in complex and chronic disorders with an integrative team of practitioners.
This broad experience has been invaluable in developing the diagnosis and treatment of chronic disorders and the ability to look beyond the existing paradigms to a deeper and more profound understanding of complex disease, particularly Chronic Fatigue Syndrome, Borreliosis and its co-infections and Auto Immune Disease.
Dr Schloeffel has treated over three and a half thousand patients with Chronic Fatigue Syndrome and related disorders, refining diagnosis and appropriate investigations and management protocols. He has lectured widely on CFS and is currently undertaking research at Sydney University into Australian Lyme Disease.
Fibromyalgia syndrome is a common and chronic disorder characterized
by widespread pain, diffuse tenderness, and a number of other symptoms.
The word “fibromyalgia” comes from the Latin term for fibrous tissue (fibro) and the Greek ones for muscle (myo) and pain (algia).
Although fibromyalgia is often considered an arthritis-related
condition, it is not truly a form of arthritis (a disease of the joints)
because it does not cause inflammation or damage to the joints,
muscles, or other tissues. Like arthritis, however, fibromyalgia can
cause significant pain and fatigue, and it can interfere with a person’s
ability to carry on daily activities. Also like arthritis, fibromyalgia
is considered a rheumatic condition, a medical condition that impairs
the joints and/or soft tissues and causes chronic pain.
In addition to pain and fatigue, people who have fibromyalgia may experience a variety of other symptoms including:
-- cognitive and memory problems (sometimes referred to as “fibro fog”)
-- sleep disturbances
-- morning stiffness
-- headaches
-- irritable bowel syndrome
-- painful menstrual periods
-- numbness or tingling of the extremities
-- restless legs syndrome
-- temperature sensitivity
-- sensitivity to loud noises or bright lights.
Fibromyalgia is a syndrome rather than a disease. A syndrome is a
collection of signs, symptoms, and medical problems that tend to occur
together but are not related to a specific, identifiable cause. A
disease, on the other hand, has a specific cause or causes and
recognizable signs and symptoms.
A person may have two or more coexisting chronic pain conditions.
Such conditions can include chronic fatigue syndrome, endometriosis,
fibromyalgia, inflammatory bowel disease, interstitial cystitis,
temporomandibular joint dysfunction, and vulvodynia. It is not known
whether these disorders share a common cause.
National Prize of Applied Sciences nominee Dr. Jorge Lolas Talhami and his research on “cyclical hysterotoxemia”. Featuring: Dr. Enrique Vazquez-Vera - MD, FACOG; Dr. Jorge Lolas Talhami; Amanda Parodi; and Yusnaiberth Rivero De Detraux.
Content presented by Dr. Enrique Vazquez-Vera - MD, FACOG at the 2015 NAPMDD National Conference 8/9/2015.
View the session video at: http://napmdd.org/denver2015nc/session-03.html
Become a member of NAPMDD at:
http://napmdd.org/join
Overview of these drug. About Pain & Fever and Mechanisms of Action with Binding Receptor. Also have Pain scale, Choice of Drug and Their Side Effect, Adverse Effect. About Misuse of These Drug & Management
Premenstrual syndrome is a combination of psychological and physical symptoms that begin during the luteal phase of menstrual life.
This presentation consists of concise content for PMS required for final year BPT students. I hope this helps you to clear your concepts for the same. Thank you for your time.
Appetite Stimulant And Suppressants.pptxGokul546572
# Definition of Appetite
# What causes a decrease in appetite
# Definition of Appetite Stimulants
# Classification of Appetite Stimulants
# Zinc
# Mechanism of action Zinc
# Thiamine
# Dronabinol
# Mechanism of action Dronabinol
# Use & Side effects of Dronabinol
# Oxandrolone
# Mechanism of action of Oxandrolone
# Use & Side effects of Oxandrolone
# Definition of Appetite Suppressants
# Classification of Appetite Suppressants
# Mechanism of action of Centrally Acting Drugs
# Side effects and other effects of Centrally acting drugs
# Definition of Serotonergic agents
# Fenfluramine
# Definition of Adrenergic Serotonergic agents
# Sibutramine
CHRONIC PAIN AND DEPRESSION: Cause or Effect or Linked?Sudhir Kumar
Chronic pain and depression are both common conditions, and in many patients, they co-exist. This presentation looks at the link between chronic pain and depression. Various drugs that can be used to treat chronic pain/depression have been discussed, with a special emphasis on tricyclic antidepressants.
1. Fibromyalgia & Chronic Fatigue
Syndrome: Theories & Therapies
Mark Burger, PharmD, RPh
Health First! Pharmacy &
Compounding Center
2. Objectives
• Review the basic information on fibromyalgia
and chronic fatigue syndrome
• Examine various theories on the cause(s) of
FM and CFS
• Consider pharmacologic and non-
pharmacologic therapies for FM and CFS
• Explore new approaches to the treatment of
FM, CFS and related syndromes
3. Fibromyalgia (FM)
• DEFINITION :: A common condition associated
with muscular pain, fatigue, and modd
changes;
• DEFINITION :: A history of widespread, “all
over” pain of at least 3 months duration with
abnormal pain sensitivity in at least 11 of 18
specific sites (tender points)
– American College of Pharmacy definition
4. Epidemiology
epidemiology /ep·i·de·mi·ol·o·gy/ (-de″me-ol´ah-je) the science concerned
with the study of the factors determining and influencing the frequency and
distribution of disease, injury, and other health-related events and their
causes in a defined human population. Also, the sum of knowledge gained in
such a study.
• Present in most countries and most ethnicities
• Present fro ages 30 to 50
• Affects, primarily, women
– Ratio of F:M = 9:1
• More prevalent in older patients
– i.e. > 50 years old
5. Pathophysiology
path·o·phys·i·ol·o·gy (pth-fz-l-j)n.1. The functional changes
associated with or resulting from disease or injury.
• No “real” cause has been determined
• Can not be diagnosed w/lab tests, x-rays, or blood tests
• Ultimately comes down to altered pain perception & is
recognized as a form of chronic pain syndrome
• Decreased REM sleep is seen
• Psychololgical abnormalities seen:
– Depression
– Anxiety
• Langford, C, Gilliand, B, “Chapter 329: Fibromyalgia”,
Harrison’s Principles of Internal Medicine
6. Symptomology
• Muscle pain
• Fatigue
• Stiffness
• Anxiety
• Depression
• Headaches
• Decreased Quality of Life (QOL)
– Langford, C, Gilliand, B, “Chapter 329: Fibromyalgia”,
Harrison’s Principles of Internal Medicine
7. Brain Chemistry & Hormonal Abnormalities
Commonly Seen in Fibromyalgia 1 of 2
• ↓ serotonin (an inhibitory neurotransmitter
found in the brain & gut)
• ↓ stress hormones due to defects in the
feedback loop from the adrenal glands to the
brain (pituitary)
– ↓ norepinephrine (NE) an excitatory
neurotransmitter. A “fight-or-flight” hormone
– Altered cortisol (a long-term “f-or-f” hormone)
• Decreased Insulin Like Growth Factor (IGF) which
is an indicator of Growth Hormone (HGH)
8. Brain Chemistry & Hormonal Abnormalities
Commonly Seen in Fibromyalgia 2 of 2
• Decreased DHEA (an adrenal hormone). Highest
in 3rd decade of life & gets lower as we age. Can
be tested in saliva as DHEA-S
• Decreased Thyroid Hormone (especially T-3)
• Decreased Melatonin
• Increased Substance-P (a neuromodulator &
neurotransmitter associated with the regulation
of mood disorders, anxiety, stress,
reinforcement, neurogenesis, respiratory rhythm,
neurotoxicity, nausea/emesis, pain and
nociception or pain perception)
9. Abnormalities in the Muscle and Cell
• Biochemical abnormalities resulting in ↓ ATP (ATP is
considered as the universal energy currency for
metabolism: ATP→ADP + Energy)
• Structural blood flow abnormalities particularly
regional cerebral blood flow (rCBF)
• Functional abnormalities due to pain and stress
(Functional abnormalities or functional deficiencies
can become a problem for the entire body. E.g. if your
shoulder or an area of your spine loses optimal
function, the workload and physical stress of that body
part is distributed to other areas of the body)
11. Adverse Effects Considerations for
Pharmacologic Agents
• Angioedema (rapid swelling or edema of the skin,
subcutaneous tissue, mucosa & submucosal
tissues)
• Suicide ideation
• Dizziness, sleepiness
• Weight gain
• Headache
• Quality of Life (QOL) issues
• “One Size (does not) Fit All”
12. Treatment of FM (non-pharmacologic)
• Physical Therapy & Graded Exercise
• Diet [gluten-free and/or vegetarian]
• Regular sleep
• Stress reduction
• Acupuncture
• Massage Therapy
• Tai Chi
13. Theories as to cause of FM
• “A large body of evidence supports the
relationship between stress and altered
activity in both the sympathetic nervous
system and hypothalamic-pituitary-adrenal
(HPA) axis [aka the “feedback loop for cortisol
and stress”].”
– The Journal of Rheumatology 2005. Vol. 32,
supplement 75.
14. Theories as to cause of FM
• Given the complexity of the symptoms associated
with FM, disturbances in the endocrine
(hormonal) system may account for some of the
associated symptoms of fibromyalgia.
• Proposed by John Lowe: Symptoms of FM are
due to inadequate thyroid conversion
↓(T4→T3). The key to proper thyroid
measurement & evaluation is NOT thyroid
production, but thyroid conversion, uptake, &
utilization.
15. T4→T3 Conversion
Active T3
Selenium & Zinc
T4 De-Iodinases
Adrenaline & Cortisol
Reverse T3
(inactive)
16. • Thyroid hormone controls metabolism.
Therefore, poor thyroid utilization could
create a hypometabolic (low metabolism)
state in FM patients.
17. Treatment per Lowe
• FM low thyroid patients need T4/T3
supplementation
• FM hypometabolic patients need T3
supplementation
• As metabolism increases, symptoms of FM
decrease
• RULE: Treat the patient, NOT the blood
tests!!!
18. FM and Dopamine (DA) Dysfunction
• Proposed by Patrick Wood
• Wood looks at FM as a stress-related disorder.
• Wood believes that prolonged exposure to
unavoidable stress produces a reduction in DA
output and development of hyperalgesia
(heightened pain perception)
• According to Wood, both serotonergic &
dopaminergic systems are impacted, but the
effect on DA appears to outlast the effect on
serotonin.
19. Treatment according to Wood
• Emphasis on total body stress, not just pain
• Uses comprehensive approach
• Suggests the use of Mirapex®/pramipexole a dopamine
agonist (sits on DA receptors)
• Melatonin
• DHEA [cream, capsule, troche ... Compounded Rx]
• T3 [Slow Release: Compounded Rx]
• Phosphatidyl serine + adrenal support
• Cortisol [Cortef® or IsoCort™ or Compounded Rx]
• Magnesium malate or Dextromethorphan for pain
• Mucuna pruriens ext. [DopaTropic Powder™/Biotics]
20. Other Approaches in the treatment of
FM
• Myofascial approach (the junction of the
fascia and the muscle) Fascia is the soft tissue component of
the connective tissue that provides support and protection for most
structures within the human body, including muscle. This soft tissue can
become restricted due to psychogenic disease, overuse, trauma,
infectious agents, or inactivity, often resulting in pain, muscle tension, and
corresponding diminished blood flow.
• This may explain the success of localized
“trigger point” therapies
22. Thyroid Measurement (metabolism)
• Evaluation survey/questionnaire
• Basal Temperature measurement
– In AM
– Immediately upon awakening
– Analogue thermometer, mercury-free
– Thyroid tests that measure T4→T3 conversion
– Treatment with dessicated thyroid or a T4/T3
combination ... NOT levothyroxine (aka T4)
23. Adrenal Measurement (stress)
• Evaluation survey / questionnaire
• Saliva cortisol measurements (4 point)
• Saliva DHEA measurement (in AM)
• Adrenal Support
• Treatment with cortisol or DHEA
24. Universally Accepted Therapies for
FM: Diet
• Well balanced diet (gluten-free or vegetarian)
• Small meals (4-5 per day)
• Fruits
• Vegetables
• Whole grains
• Skinless poultry and fish
• Eliminate caffeine, sugar, and alcohol
25. Universally Accepted Therapies for
FM: Exercise
• REGULAR exercise
• Start SLOW
• Short times of walking or swimming
• Stretch properly (myofascial release)
• Accountability partner
26. Universally Accepted Therapies for
FM: Sleep
• Establish and maintain normal sleeping
routine
• Avoid caffeine and drinking for the entire day,
not just at night. Caffeine can alter cortisol for
24 hours after drinking
• Consider switching medications from bedtime
to morning
27. Universally Accepted Therapies for
FM: Stress Reduction
• Avoid stress triggers
• Use stress reduction techniques (meditation,
breathing, Tai Chi, Quigong, walks in Nature.
• Find enjoyable activities/hobbies
• Use support groups
28. Supplements
• ↓ inflammation with MEDICAL FOODS (e.g.
UltraInflamx™)
• ↓ inflammation with Fish Oil 1200-1500
mg/day (esp. the ones high in EPA)
• Curcumin w/absorption enhancement
• Improve mitochondrial function w/CoQ-10
and mitochondrial numbers w/PQQ & Resv.
• Improve mitochonrial energy w/L-carnitine
• Improve energy production w/Resveratrol
30. Fatigue (Thyroid Based): Following
appropriate eval + testing
• Thyroid support products
• Iodine + Tyrosine (tyrosine is the main
building block of the thyroid hormone. It is an
amino acid)
• Ribose (a sugar that enters into an alternate
pathway to provide energy after the usual
sources have been depleted) [Corvalen-M™]
32. Sleep (problems with sleep can be
MORE problematic than pain
management)
• Goal is to restore normal sleep cycles & sleep
activity
• Therapy should be non-addictive
• Non-interactive with other medications
• Customized to needs of patient